Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Nucynta (tapentadol hydrochloride)
pCPA File Number:
21067
Negotiation Status:
Negotiations were not pursued
Indication(s):
Pain, severe
Sponsor/Manufacturer:
Paladin Labs Inc.
CADTH Project Number:
SR0563-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
2018-11-29